CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) — Aptar Digital Well being, a worldwide chief in digital well being options enhancing the affected person expertise, and Allow Injections, Inc. (“Enable”), a healthcare innovation firm creating and manufacturing the enFuse® On-Physique Supply System, right this moment introduced a strategic partnership naming Aptar Digital Well being as Allow’s most popular digital well being companion for the enFuse® system. This digital resolution will be designed to information sufferers and caregivers all through the injection course of and assist strengthen engagement assist earlier than, throughout and after administration.
By way of this partnership, Aptar Digital Well being will ship a companion digital resolution for Allow Injections’ enFuse® system, designed to reinforce the affected person expertise and assist adherence. Key options of the answer will embody remedy knowledge recording, onboarding and coaching modules, injection steering, patient-reported outcomes and symptom monitoring – serving to to empower sufferers and caregivers with better confidence and management over the remedy course of.
Constructed on a versatile and scalable structure, the companion resolution will likely be deployed alongside the enFuse® system, enabling pharmaceutical companions to increase the worth of their therapies past supply. Designed to evolve throughout the drug improvement lifecycle, the answer will assist use instances from medical trials via commercialization, aligned with improvement and launch methods.
Adherence knowledge and affected person reported outcomes will likely be captured remotely, securely saved and made out there via analytics dashboards that generate actionable insights to assist medical improvement, launch readiness and real-world use. The modular, program-specific design will permit pharmaceutical companions to combine digital elements into their medical or business applications primarily based on their wants. By combining device-generated knowledge with affected person reported insights, the answer will assist drive extra knowledgeable selections grounded in real-world utilization.
“The enFuse® companion solution reflects our vision of a more connected treatment experience that supports patients beyond the moment of injection,” mentioned Michael D. Hooven, Chairman and CEO of Allow Injections. “Together with Aptar Digital Health, we aim to combine innovative drug delivery with digital support tools that can help patients remain engaged in their therapy and enable healthcare providers to better understand and support each patient’s journey.”
More Read
“We are excited to partner with Enable Injections to help bring the next generation of drug delivery solutions to life,” mentioned Damien McKeon, SVP Strategic Partnerships, Aptar Digital Well being. “Large-volume biologic therapies are increasingly used to treat complex chronic conditions. They often require long-term adherence to achieve optimal outcomes. Digital solutions supporting treatment tracking and patient engagement can help address common adherence challenges associated with self-administration.”
About Aptar Digital Well being Aptar Pharma’s Digital Well being division is a part of AptarGroup, Inc. (NYSE:ATR), a worldwide chief in drug supply, together with dosing and safety applied sciences, and shopper product meting out. Aptar Digital Well being creates end-to-end options to reinforce affected person experiences day-after-day, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of merchandise and options, Aptar Digital Well being’s providing combines cellular and internet apps, Software program-as-Medical-System, linked drug supply programs, superior knowledge evaluation providers, and affected person onboarding and coaching options to actively empower sufferers and create a optimistic remedy journey. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 devoted individuals throughout 20 international locations. Be taught extra at www.aptardigitalhealth.com and http://www.aptar.com.
About Allow InjectionsCincinnati-based Allow Injections is a worldwide healthcare innovation firm dedicated to bettering the affected person remedy expertise via the event and manufacturing of the enFuse® on-body drug supply system. An revolutionary wearable know-how, the enFuse® system is designed to ship giant volumes of pharmaceutical and biologic therapeutics by way of subcutaneous administration, with the intention of bettering comfort, supporting improved outcomes, and advancing healthcare system economics.
More Read
Allow is at present working with plenty of pharmaceutical companions to conduct medical trials and plan for the joint business launch of their therapies together with the enFuse® know-how. For extra info, go to www.enableinjections.com.
